Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Amneal Pharmaceuticals, Inc.
AMRX
Supplies Expense
Supplies Expense at other companies
Bank of the James Financial Group
BOTJ
$160K
+12.7%
United Bancorp
UBCP
$32K
+3.2%
UMB Financial
UMBF
$5.5M
-13.8%
ARD
Ardent Health Partners
ARDT
$268.55M
+3.7%
Encompass Health Corporation
EHC
$64.3M
+3.4%
Acadia Healthcare
ACHC
$30.2M
+5.8%
Segments
By segment
See full
Affordable Medicines
$8.8M
+8.5%
Other financials
Income statement
See full
Revenue
$796.2M
+9.9%
Gross profit
$334.5M
+16.9%
Operating income
$129.8M
+16.5%
Net income
$57.7M
+157%
EPS (diluted)
$0.18
+157%
Balance sheet
See full
Cash & equivalents
$127.6M
+78.4%
Total debt
$2.6B
+18.0%
Total equity
$33.0M
+129%
Total assets
$3.8B
+10.3%
Cash flow
See full
Operating cash flow
-$21.2M
-125%
CapEx
$30.7M
+34.5%
Free cash flow
-$51.9M
-185%
Valuation
See full
Market cap
$5.77B
+129%
Enterprise value
$8.21B
+77.4%
P/E
36.7×
-711×
P/S
1.9×
+1.0×
Profitability
See full
Gross margin
39.3%
+1.7pp
Operating margin
14.6%
+1.4pp
Net margin
5%
+4.9pp
FCF margin
4.1%
-5.8pp
Returns & leverage
See full
Return on equity
-52.8%
-12.7pp
Debt / equity
77.8×
—
Current ratio
2.2×
+0.8×
Watchlist
Screener
Filings
Earnings
Charts